MORGAN STANLEY - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$20,262,771
+5.0%
1,592,985
+16.2%
0.00%0.0%
Q2 2023$19,299,584
+33.8%
1,370,709
+46.8%
0.00%0.0%
Q1 2023$14,427,148
+44.5%
933,796
+53.3%
0.00%
+100.0%
Q4 2022$9,985,739
-10.3%
609,258
+1.3%
0.00%
-50.0%
Q3 2022$11,131,000
-6.7%
601,703
-33.7%
0.00%0.0%
Q2 2022$11,929,000
+85.8%
907,196
+31.0%
0.00%
+100.0%
Q1 2022$6,421,000
+181.9%
692,624
+197.1%
0.00%
Q4 2021$2,278,000
+42.9%
233,120
+396.7%
0.00%
Q3 2021$1,594,000
-1.3%
46,931
+6.3%
0.00%
Q2 2021$1,615,000
+86.7%
44,132
+128.7%
0.00%
Q1 2021$865,000
-60.8%
19,298
-50.1%
0.00%
Q4 2020$2,207,000
+247.0%
38,665
+211.3%
0.00%
Q3 2020$636,000
-88.9%
12,420
-87.0%
0.00%
-100.0%
Q2 2020$5,722,000
+405.9%
95,819
+248.4%
0.00%
Q1 2020$1,131,000
-52.5%
27,502
-28.2%
0.00%
-100.0%
Q4 2019$2,383,000
-79.4%
38,289
-88.8%
0.00%
-66.7%
Q3 2019$11,572,000
+6437.9%
340,956
+4235.7%
0.00%
Q2 2019$177,000
+205.2%
7,864
+214.8%
0.00%
Q1 2019$58,000
-93.6%
2,498
-94.2%
0.00%
Q4 2018$904,000
+57.8%
43,099
+191.1%
0.00%
Q3 2018$573,000
-16.7%
14,804
-15.3%
0.00%
Q2 2018$688,000
+124.1%
17,484
+14.2%
0.00%
Q1 2018$307,000
-5.8%
15,309
+6.3%
0.00%
Q4 2017$326,00014,3980.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$11,213,0005.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,580,456$51,731,0001.16%
ARMISTICE CAPITAL, LLC 5,836,000$54,100,0001.05%
Pinz Capital Management, LP 165,835$1,537,0000.96%
Sunesis Advisors, LLC 96,299$893,0000.52%
Redmile Group, LLC 664,817$6,163,0000.19%
PDT Partners, LLC 222,343$2,061,0000.18%
Bayesian Capital Management, LP 41,900$388,0000.06%
Laurion Capital Management LP 459,290$4,258,0000.05%
Hennion & Walsh Asset Management, Inc. 101,643$942,0000.05%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders